Cargando…

Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer

Ovarian cancer (OC) is a devastating malignancy with a poor prognosis. The complex tumor immune microenvironment results in only a small number of patients benefiting from immunotherapy. To explore the different factors that lead to immune invasion and determine prognosis and response to immune chec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhao-Cong, Guo, Jun-Nan, Zhang, Ning, Wang, Zhi-Qiang, Lou, Ge, Cui, Bin-Bin, Yang, Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645858/ https://www.ncbi.nlm.nih.gov/pubmed/34880862 http://dx.doi.org/10.3389/fimmu.2021.763791

Ejemplares similares

Identification and Validation in a Novel Quantification System of Ferroptosis Patterns for the Prediction of Prognosis and Immunotherapy Response in Left- and Right-Sided Colon Cancer
por: Zhang, Heng-Chun, et al.
Publicado: (2022)

Identification and Validation of Immune-Related Methylation Clusters for Predicting Immune Activity and Prognosis in Breast Cancer
por: Yang, Anli, et al.
Publicado: (2021)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
por: Li, Ruiyu, et al.
Publicado: (2021)

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
por: Yang, Chang, et al.
Publicado: (2020)

Construction of an Immune Cell Infiltration Score to Evaluate the Prognosis and Therapeutic Efficacy of Ovarian Cancer Patients
por: Liu, Jinhui, et al.
Publicado: (2021)

Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer
por: Wang, Zitao, et al.
Publicado: (2022)

Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer
por: Peng, Yang, et al.
Publicado: (2021)

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2022)

Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma
por: Ma, Xiaochen, et al.
Publicado: (2022)

Construction and validation of an angiogenesis-related scoring model to predict prognosis, tumor immune microenvironment and therapeutic response in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2022)

Identification of Immune-Related LncRNA Pairs for Predicting Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma
por: Wang, Xueying, et al.
Publicado: (2021)

Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma
por: Hu, Yuanyuan, et al.
Publicado: (2022)

Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature
por: Fu, Denggang, et al.
Publicado: (2021)

Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential
por: Pi, Ya-Nan, et al.
Publicado: (2021)

Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma
por: Sae-fung, Apiwit, et al.
Publicado: (2023)

A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer
por: Wang, Haoyu, et al.
Publicado: (2022)

Corrigendum: Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential
por: Pi, Ya-Nan, et al.
Publicado: (2022)

Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer
por: Ye, Lele, et al.
Publicado: (2019)

Cervical cancer immune infiltration microenvironment identification, construction of immune scores, assisting patient prognosis and immunotherapy
por: Yao, Shijie, et al.
Publicado: (2023)

Bioinformatics identification and validation of biomarkers and infiltrating immune cells in endometriosis
por: Jiang, Hong, et al.
Publicado: (2022)

Identification and validation of a novel anoikis-related signature for predicting prognosis and immune landscape in ovarian serous cystadenocarcinoma
por: Zhu, Yu-Ting, et al.
Publicado: (2023)

Identification of immune related gene signature for predicting prognosis of cholangiocarcinoma patients
por: Zhang, Zi-jian, et al.
Publicado: (2023)

Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration
por: Jiang, Xiu-Feng, et al.
Publicado: (2022)

A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma
por: Wang, Xiaoxuan, et al.
Publicado: (2022)

Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis
por: Yan, Zongcai, et al.
Publicado: (2021)

Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy
por: Guo, Yangyang, et al.
Publicado: (2023)

Deciphering the immune landscape dominated by cancer-associated fibroblasts to investigate their potential in indicating prognosis and guiding therapeutic regimens in high grade serous ovarian carcinoma
por: Li, Yimin, et al.
Publicado: (2022)

Machine learning-based integration develops an immune-related risk model for predicting prognosis of high-grade serous ovarian cancer and providing therapeutic strategies
por: Wu, Qihui, et al.
Publicado: (2023)

SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis
por: Gutiérrez-Chamorro, Lucía, et al.
Publicado: (2023)

Identification and validation of SNHG gene signature to predict malignant behaviors and therapeutic responses in glioblastoma
por: Fan, Yang, et al.
Publicado: (2022)

Screening and Validation of the Hypoxia-Related Signature of Evaluating Tumor Immune Microenvironment and Predicting Prognosis in Gastric Cancer
por: Pei, Jun-Peng, et al.
Publicado: (2021)

Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy
por: Guo, Yangyang, et al.
Publicado: (2023)

The Gradient of Immune/Inflammatory Response and COVID-19 Prognosis with Therapeutic Implications
por: Zheng, Ming
Publicado: (2021)

Immune infiltration landscape on prognosis and therapeutic response and relevant epigenetic and transcriptomic mechanisms in lung adenocarcinoma
por: Zhang, Liangming, et al.
Publicado: (2022)

Fatty Acid Metabolic Signaling Pathway Alternation Predict Prognosis of Immune Checkpoint Inhibitors in Glioblastoma
por: Liu, Rongrong, et al.
Publicado: (2022)

Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment efficacy, and drug candidates
por: Guo, Chengbin, et al.
Publicado: (2022)

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Zeng, Weibiao, et al.
Publicado: (2023)

Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis
por: Kong, Yang, et al.
Publicado: (2020)

Integrated single-cell multiomics reveals novel immune candidate markers for post-traumatic coagulopathy
por: Zheng, Ping, et al.
Publicado: (2023)

Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinoma
por: Li, Qiaxuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_98b53r8k3fol5uqs8t4lnmt81s